SIM
SGYP

SSI Investment Management’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

SSI Investment Management’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-70,500
Closed -$215K – 368
2014
Q4 		$215K Buy
+70,500
New +$209K 0.02% 331

Other funds holding SGYP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SSI Investment Management's SGYP Position: Q1 2015 in Review

SSI Investment Management sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2015, closing a stake of 70,500 shares — an estimated $215K sold.

SSI Investment Management first reported a position in SGYP in Q4 2014 and held it in 1 quarter. The position peaked at $215K in Q4 2014. 85 funds tracked by Wall St. Rank hold SGYP as of Q1 2015.

  • SSI Investment Management reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2015 after selling out during the quarter.
  • SSI Investment Management sold 70,500 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2015, an estimated $215K.
  • SSI Investment Management first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q4 2014 and held it in 1 quarter.
  • SSI Investment Management's Synergy Pharmaceuticals, Inc Common Stock position peaked at $215K in Q4 2014.
  • 85 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2015.

Based on SSI Investment Management's 13F filing for Q1 2015, filed 12 May 2015.